Tag: Diabetes: Type II

Reduced risk for Alzheimer disease, vascular dementia, and Parkinson disease seen with SGLT2i use in type 2 diabetes

Lower diligence level linked to risk for new cardiovascular disease, but healthy lifestyle still beneficial

Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage

Once-weekly efsitora noninferior to once-daily degludec for decrease in mean glycated hemoglobin level

Those with late versus intermediate chronotype also have higher BMI, larger waist circumference, more visceral fat and liver fat

Authors say inverse association may be explained by hyperinsulinemia

Findings seen among patients with newly diagnosed type 2 diabetes

Risk increased in association with consumption of 100 g/day red meat, 50 g/day processed meat

Omnipod 5 works in concert with a continuous glucose monitor to manage blood glucose with no daily injections and no finger pricks

Estimated risk difference varied from −2.45 to 0.63 percentage points with SGLT2 versus dulaglutide among older adults